LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial
2024 · Annals of Oncology · 30 citations
https://doi.org/10.1016/j.annonc.2024.08.2320